Reduced cardiac output and decreased blood pressure, seen in ErbB2 transgenic mice, are other features often observed in HCM human patients particularly during exercise tests [72] and hypertrophic cardiomyopathy mouse models [73], [74]. This evidence concerns the gene ERBB2 and hypertrophic cardiomyopathy.